Joseph Kim | Source | Chief Strategy Officer at ProofPilot
Joseph Kim
As Chief Strategy Officer, Joseph Kim brings over 23 years of pharmaceutical expertise to ProofPilot. Most recently serving in a senior leadership role as Senior Advisor in Lilly’s Digital Health Office, he brings a wide array of pharmaceutical research industry knowledge, integrating his experience working for a wide variety of organizations, including multiple Sponsors such as Merck and Takeda (Shire), as well as CROs, and technology vendors. He has a robust combination of experience across all phases of clinical research, and a well-known history of innovation in the industry, recognized as one of the “Top 100 individuals on the 2015 MedicineMakers Power List,” and “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova.
-
ProofPilot
Chief Strategy Officer
started Jan 2022 -
Eli Lilly and Company (http://www.lilly.com/)
Senior Advisor, Clinical Research Digital Health
Jul 2014 – Jan 2022 -
Takeda Pharmaceutical Company Ltd (https://www.takeda.com/)
Director, Clinical Operations
Jun 2009 – Jul 2014
-
Elixir Factor Podcast
The Elixir Factor, Lilly’s new podcast hosted by Joe Kim, senior advisor of patient experience and design, explores the factors that inspire bold advances in science, innovation and the resilience req
Podcast -
Clinical Trials may be Compromised by Online Patient Chatter
Are patients jeopardizing clinical trials by discussing them on social media? There is growing fear in the medical community and the pharmaceutical industry that an increasing number of people who participate in clinical trials may indeed compromise research by chatting about treatments, side effects and enrollment tips on Facebook, online forums and blogs.
Article
